600329.SH
达仁堂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 35.72
+1.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 26.84x
- P/E 2027E
- 23.35x
- P/E 2028E
- 21.03x
- P/S forward
- 10.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.91x
- PEG TTM
- 0.48x
- Price / book
- 4.63x
- Price / sales
- 5.56x
- Price / cash flow
- 52.48x
Enterprise value
- Enterprise value
- CNY 26.8B
- EV / sales
- 5.39x
- EV / EBITDA
- 10.28x
- EV / EBIT
- 10.55x
- Market cap
- CNY 27.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026